Eagle Strategies LLC Purchases Shares of 975 The Cigna Group (NYSE:CI)

Eagle Strategies LLC purchased a new stake in The Cigna Group (NYSE:CI - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 975 shares of the health services provider's stock, valued at approximately $269,000.

Several other large investors have also recently bought and sold shares of CI. Kesler Norman & Wride LLC boosted its stake in shares of The Cigna Group by 1.8% during the 4th quarter. Kesler Norman & Wride LLC now owns 2,033 shares of the health services provider's stock worth $562,000 after acquiring an additional 35 shares during the period. Hudson Edge Investment Partners Inc. raised its position in The Cigna Group by 1.9% during the fourth quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider's stock valued at $520,000 after purchasing an additional 36 shares in the last quarter. Meridian Wealth Management LLC lifted its position in shares of The Cigna Group by 1.0% during the 4th quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider's stock worth $1,013,000 after buying an additional 37 shares during the last quarter. Mindset Wealth Management LLC boosted its stake in shares of The Cigna Group by 2.6% in the 4th quarter. Mindset Wealth Management LLC now owns 1,469 shares of the health services provider's stock valued at $406,000 after purchasing an additional 37 shares in the last quarter. Finally, Jacobi Capital Management LLC increased its holdings in shares of The Cigna Group by 2.2% during the fourth quarter. Jacobi Capital Management LLC now owns 1,749 shares of the health services provider's stock worth $483,000 after buying an additional 38 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Insider Transactions at The Cigna Group

In other news, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elder Granger sold 2,376 shares of the company's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the sale, the director now owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. This trade represents a 30.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock valued at $13,603,991 in the last quarter. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on CI shares. StockNews.com raised shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Morgan Stanley increased their price objective on shares of The Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research report on Monday. Piper Sandler upped their price objective on shares of The Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a report on Monday. Barclays increased their price target on The Cigna Group from $339.00 to $382.00 and gave the company an "overweight" rating in a research report on Monday. Finally, Wells Fargo & Company cut their target price on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 4th. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, The Cigna Group has a consensus rating of "Buy" and a consensus target price of $378.22.

The Cigna Group Stock Up 0.3 %

Shares of NYSE:CI traded up $1.00 during midday trading on Tuesday, reaching $334.01. The company's stock had a trading volume of 1,793,231 shares, compared to its average volume of 1,698,561. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The firm has a market capitalization of $91.41 billion, a P/E ratio of 27.29, a PEG ratio of 0.98 and a beta of 0.47. The firm has a 50 day moving average of $323.77 and a 200-day moving average of $309.57. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.35 by $0.39. The firm had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business's revenue was up 14.4% on a year-over-year basis. During the same period last year, the business earned $6.47 earnings per share. On average, research analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.81%. The Cigna Group's payout ratio is presently 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.